Dacomitinib is an EGFR inhibitor used to treat Non-Small Cell Lung Cancer. It’s for people who have certain gene mutations. It’s made to focus on patients who have specific EGFR mutations like the 19 deletion or the L858R mutation.
You can get this med in tablet form in 3 doses—15, 30, or 45 mg. The usual dose is 45 mg and you take it just once a day. These tabs are coated and sold in bottles of 30.
It works by blocking the EGFR pathway, which is really important in treating NSCLC.
